Annual prepayment can lower a printed monthly equivalent while increasing the amount at risk before the first supply arrives. A care membership and a medicine-inclus
Annual prepayment can lower a printed monthly equivalent while increasing the amount at risk before the first supply arrives. A care membership and a medicine-inclusive annual plan also purchase different things. This list compares two explicit prepaid models with three alternatives that clarify the tradeoff.
Injection Index does not assume that a longer commitment improves treatment outcomes. The useful comparison is the complete advance charge, what it includes and what can be canceled or refunded. A monthly offer beside an annual plan is included as a separate commitment option, not mislabeled as annual.
Compounded semaglutide $99/mo; tirzepatide $149/mo; no membership fee
A stated monthly compounded-medicine price, with important prescription and refund checkpoints.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
Semaglutide monthly; $99/mo equivalent annual commitment billed $1,188 upfront
Trimi explicitly separates an annual monthly equivalent from the upfront bill: semaglutide is advertised at $1,188 for twelve months, with a different month-to-month rate.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
Membership then $149/mo monthly or $74/mo equivalent prepaid annually; medicine extra
Ro separates the cost of its care membership from the prescription cost.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
Compounded semaglutide $69; tirzepatide $119; promotion and term conditions
SnagRx advertises low flat monthly prices, but longer subscription terms and its medically limited refund rule qualify the cancellation headline.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
GLP-1 from $89; GLP-1 plus GIP from $149; selected preparation and terms apply
AltRx’s low starting GLP-1 rate sits alongside different compounded and branded offers; paid testimonials and complete plan terms need their own reading.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
Compare the total term payment and medication inclusion before looking at the equivalent. Ro’s prepaid rate concerns membership with medication extra; Trimi’s annual quote concerns a compounded supply pathway. Monthly bundled and term-discount options are different alternatives. Ask what happens if prescribing is declined, treatment changes or a patient needs to stop before the term ends. Read the related care guide for a wider treatment discussion.
CoreAge provides clinician assessment and a compounded injection pathway with a stated ingredient-specific starting rate. Its product pages separate semaglutide from tirzepatide. The prescription, concentration and amount dispensed should be confirmed rather than inferred from the price or transferred from another provider’s vial instructions. CoreAge’s stated monthly offer provides a separate benchmark for limiting a long advance commitment. Confirm the actual order and refund deadlines rather than assuming the absence of a membership fee guarantees full flexibility after pharmacy approval.
CoreAge’s current product pages list compounded semaglutide at $99 per month and compounded tirzepatide at $149, with no membership fee and free delivery if prescribed. Confirm the actual amount, billing interval and dispensing pharmacy. Its refund policy has pharmacy-approval and elapsed-time limits; cancellation should not be assumed to refund a prepared prescription.
Read the full CoreAge Rx review to compare the care pathway, prescription and recurring order.
Trimi describes individualized compounded semaglutide and tirzepatide prescriptions with provider review, supplies and shipment. It offers materially different annual and monthly payment commitments. The named pharmacy pathway helps identify what to ask, while regulatory status and clinical rationale still need separate consideration. The annual equivalent and full advance bill are both explicit. The patient should compare that commitment with Trimi’s monthly option and ask how a clinical change affects the prepaid remaining term.
Trimi’s current compounded semaglutide choices are $175 month-to-month or a $99 monthly equivalent on a twelve-month commitment billed $1,188 upfront. Tirzepatide is $235 monthly or $125 equivalent with $1,500 upfront. It lists provider review, supplies and shipping with no membership fee. Confirm selected term, actual amount supplied and refund rules; the annual equivalent is not a monthly payment.
Read the full Trimi review to compare the care pathway, prescription and recurring order.
Ro’s Body route separates a clinical membership from medication. The current page describes access to FDA-approved products, insurance support, provider messaging and care. That structure is useful to compare with medicine-inclusive bundles, while a membership floor alone does not identify the total treatment cost. Ro’s annual equivalent purchases access rather than the complete medicine supply. Add the selected pharmacy cost and determine whether its billing has a different period before comparing the annual total with a medication-inclusive plan.
Ro currently charges $39 for the first membership month, then $149 month-to-month or a $74 monthly equivalent on annual prepayment. Six- and three-month equivalents are $89 and $99, respectively. Medication is extra and depends on product, dose and coverage; branded-injection starting offers have dose and eligibility conditions. Confirm the entire advance charge, next renewal and pharmacy supply.
Read the full Ro review to compare the care pathway, prescription and recurring order.
SnagRx describes a clinician-reviewed compounded supply with a patient portal for refills. Its marketing separates no-membership pricing from selected subscription discounts. The product and pharmacy remain individualized prescription facts, while its prominent promotional price needs a term and renewal check. Subscribe-and-save discounts can change both rate and commitment. Obtain the selected term and complete payment rather than treating the general cancel-anytime language as a promise of an unused-term refund in every situation.
SnagRx currently promotes compounded semaglutide at $69 and tirzepatide at $119 per month, with medication, supplies, doctor review and free shipping described as included. It distinguishes month-to-month cancellation from subscribe-and-save term discounts. Sales are generally final, with unused-term refunds tied to medical ineligibility. Confirm promotion eligibility, selected term, quantity and renewal before treating the floor as guaranteed indefinitely.
Read the full SnagRx review to compare the care pathway, prescription and recurring order.
AltRx’s self-pay pathway includes a medical review and pharmacy fulfillment when appropriate. The page names independently operated pharmacy partners and distinguishes its compounded offers from branded product listings. A low promotional rate does not establish equivalent outcomes or FDA approval of the compounded preparation. AltRx’s stated inclusion offers another contrast with a prepaid access membership. Confirm the actual recurring agreement and amount supplied; the public low monthly floor should not be converted into an annual contract without evidence.
AltRx currently displays a GLP-1 offer from $89 per month and GLP-1 plus GIP from $149, with separate branded product prices. Its membership includes consultation, prescription fulfillment when appropriate, shipping and clinician support; no separate membership fee is advertised. Confirm the actual compound, dispensed quantity and recurring terms. Self-reported member outcomes are not independent clinical evidence.
Read the full AltRx review to compare the care pathway, prescription and recurring order.
An annual option should be chosen with its entire commitment visible. If treatment is new or circumstances may change, compare a shorter suitable plan as well. A lower equivalent is useful arithmetic only when the supply, care and refund terms are clear enough to assess the real obligation.
Clinical care can change during a payment term. A prescriber should review response and suitability rather than continuing medicine merely because it was prepaid. Keep the actual compound or branded product identified, and do not borrow trial outcomes to justify a longer financial commitment.
Continue with Best GLP-1 programs with insurance support and a separate self-pay alternative and Best GLP-1 programs for first-time patients: five routes before the first supply.
Explore the review directory and full cost table to compare the details of another offer.
Official public information reviewed October 1, 2026. Advertising describes an offer; it is not independent verification of treatment outcomes.
Build a useful comparison from the next invoice, not the smallest number on the page.
Read the guide →The ingredient name is the beginning of the medicine discussion, not the complete answer.
Read the guide →Bring the information that turns an online assessment into a useful medical discussion.
Read the guide →